Alogliptin (Perrigo New York Inc)
Welcome to the PulseAid listing for the Alogliptin drug offered from Perrigo New York Inc. This Dipeptidyl Peptidase 4 Inhibitors [MoA],Dipeptidyl Peptidase 4 Inhibitor [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Perrigo New York Inc |
| NON-PROPRIETARY NAME: | Alogliptin |
| SUBSTANCE NAME: | ALOGLIPTIN BENZOATE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Dipeptidyl Peptidase 4 Inhibitors [MoA],Dipeptidyl Peptidase 4 Inhibitor [EPC] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET, FILM COATED |
| MARKETING CATEGORY NAME: | NDA AUTHORIZED GENERIC |
| START MARKETING DATE: | 2016-04-08 |
| END MARKETING DATE: | 0000-00-00 |
Alogliptin HUMAN PRESCRIPTION DRUG Details:
| Item Description | Alogliptin from Perrigo New York Inc |
| LABELER NAME: | Perrigo New York Inc |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 6.25(mg/1) |
| START MARKETING DATE: | 2016-04-08 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 45802-087_f66205f2-4a06-4bb3-9a71-3ce8891fc08c |
| PRODUCT NDC: | 45802-087 |
| APPLICATION NUMBER: | NDA022271 |
Other ALOGLIPTIN BENZOATE Pharmaceutical Manufacturers / Labelers:
